CY1109549T1 - Μεθοδος καταπολεμησης λοιμωξης - Google Patents

Μεθοδος καταπολεμησης λοιμωξης

Info

Publication number
CY1109549T1
CY1109549T1 CY20091101129T CY091101129T CY1109549T1 CY 1109549 T1 CY1109549 T1 CY 1109549T1 CY 20091101129 T CY20091101129 T CY 20091101129T CY 091101129 T CY091101129 T CY 091101129T CY 1109549 T1 CY1109549 T1 CY 1109549T1
Authority
CY
Cyprus
Prior art keywords
infection
tretazicar
host organism
spp
parasitic
Prior art date
Application number
CY20091101129T
Other languages
English (en)
Inventor
Philip John Burke
Roger Melton
Richard John Knox
Original Assignee
Morvus Technology Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morvus Technology Ltd. filed Critical Morvus Technology Ltd.
Publication of CY1109549T1 publication Critical patent/CY1109549T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Μέθοδος καταπολέμησης μιας παρασιτικής πρωτοζωικής λοίμωξης ενός ξενιστή οργανισμού, η δε μέθοδος περιλαμβάνει χορήγηση τρεταζικάρης στον οργανισμό ξενιστή. Η τρεταζικάρη είναι η ένωση 5-(αζιριδιν-1-υλ)-2,4-δινιτροβενζαμίδιο (CB 1954) και η παρασιτική λοίμωξη κατά προτίμηση είναι μία λοίμωξη του Trypanosoma cruzi, T.b. brucei, Leismania spp., ιδιαιτέρως L. Infantum, Cryptosporidium ή Giardia spp.
CY20091101129T 2005-09-03 2009-10-29 Μεθοδος καταπολεμησης λοιμωξης CY1109549T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517957.7A GB0517957D0 (en) 2005-09-03 2005-09-03 Method of combating infection
EP06779273A EP1933829B1 (en) 2005-09-03 2006-09-04 Method of combating infection

Publications (1)

Publication Number Publication Date
CY1109549T1 true CY1109549T1 (el) 2014-08-13

Family

ID=35220805

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101129T CY1109549T1 (el) 2005-09-03 2009-10-29 Μεθοδος καταπολεμησης λοιμωξης

Country Status (17)

Country Link
US (1) US8415334B2 (el)
EP (1) EP1933829B1 (el)
CN (1) CN101282723B (el)
AR (1) AR055409A1 (el)
AT (1) ATE437638T1 (el)
BR (1) BRPI0615448A2 (el)
CA (1) CA2620398C (el)
CY (1) CY1109549T1 (el)
DE (1) DE602006008162D1 (el)
DK (1) DK1933829T3 (el)
EC (1) ECSP088328A (el)
ES (1) ES2356330T3 (el)
GB (1) GB0517957D0 (el)
MY (1) MY144154A (el)
PL (1) PL1933829T3 (el)
PT (1) PT1933829E (el)
WO (1) WO2007026166A2 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0526552D0 (en) 2005-12-29 2006-02-08 Morvus Technology Ltd New use
GB2442202A (en) 2006-09-30 2008-04-02 Morvus Technology Ltd Vermin poison
US9173898B2 (en) 2010-10-12 2015-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208999A (en) * 1964-09-09 1965-09-28 Nat Starch Chem Corp Preparation of non-inhibited starch amines
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
CA1089763A (en) * 1978-10-30 1980-11-18 Willard J. Johnson Rodenticide comprising 6-aminonicotinamide and 6- aminonicotinohydroxamic acid
CS204501B1 (en) 1978-11-06 1981-04-30 Miroslav Dub Shaped trap for regulation of the numbers of exoantropous and hemisynantropous rodents classes
US4375394A (en) * 1982-03-11 1983-03-01 Eastman Kodak Company Electrolytic process for the preparation of ethylene glycol and glycerine
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB8804068D0 (en) 1988-02-22 1988-03-23 Roberts J R Improvements relating to control of neoplastic tissue growth
CH680180B5 (el) * 1988-07-29 1993-01-15 Ciba Geigy Ag
DE3833194A1 (de) 1988-09-30 1990-04-05 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
DE4103639A1 (de) 1991-02-07 1992-08-13 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
JP4115514B2 (ja) * 1991-10-23 2008-07-09 キャンサー・リサーチ・キヤンペーン・テクノロジー・リミテツド Ｃｂ １９５４およびその類似体を細胞障害性の形態に還元するための細菌のニトロリダクターゼ
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE4425436A1 (de) * 1994-07-19 1996-01-25 Basf Ag Verfahren zur Herstellung von Acyloinen
GB9415167D0 (en) 1994-07-27 1994-09-14 Springer Caroline J Improvements relating to cancer therapy
US5632782A (en) * 1994-09-01 1997-05-27 Clariant Finance (Bvi) Ltd. Exhaust dyeing process for sulphur dyes
US20040053208A1 (en) 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
AU1166097A (en) 1995-12-21 1997-07-17 British Technology Group Limited Indoloquinone derivatives as bioreductive agents
ES2206891T3 (es) 1997-02-11 2004-05-16 The Victoria University Of Manchester Conjugados bioreductivos para el direccionamiento de medicamentos.
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
GB2365338B (en) 1997-06-14 2002-04-03 Enzacta R & D Ltd Therapeutic systems
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
US6159706A (en) 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
WO1999061409A1 (en) 1998-05-22 1999-12-02 Shionogi Bioresearch Corp. Bioreductive cytotoxic agents
JP2002523382A (ja) 1998-08-19 2002-07-30 ザ・ビクトリア・ユニバーシテイ・オブ・マンチエスター 薬物ターゲティング
CN1418224A (zh) 2000-03-02 2003-05-14 Ml实验室公开有限公司 Tcf效应元件
DE10049468A1 (de) * 2000-10-06 2002-04-11 Bayer Ag N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US20030228285A1 (en) * 2002-05-03 2003-12-11 Mien-Chie Hung Bipartite T-cell factor (Tcf)-responsive promoter
GB0223696D0 (en) 2002-10-14 2002-11-20 Ml Lab Plc Improved immunotherapy
CA2570245A1 (en) 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections

Also Published As

Publication number Publication date
EP1933829A2 (en) 2008-06-25
PL1933829T3 (pl) 2010-01-29
EP1933829B1 (en) 2009-07-29
BRPI0615448A2 (pt) 2011-05-17
CN101282723A (zh) 2008-10-08
US20100273762A1 (en) 2010-10-28
ES2356330T3 (es) 2011-04-07
ECSP088328A (es) 2008-08-29
US8415334B2 (en) 2013-04-09
WO2007026166A2 (en) 2007-03-08
ATE437638T1 (de) 2009-08-15
MY144154A (en) 2011-08-15
CN101282723B (zh) 2012-06-13
CA2620398A1 (en) 2007-03-08
CA2620398C (en) 2010-11-30
DK1933829T3 (da) 2009-11-30
WO2007026166A3 (en) 2007-06-28
DE602006008162D1 (de) 2009-09-10
GB0517957D0 (en) 2005-10-12
AR055409A1 (es) 2007-08-22
PT1933829E (pt) 2009-11-04

Similar Documents

Publication Publication Date Title
CY1106486T1 (el) Μεθοδος παρασκευης 2-(κινοξαλιν-5-υλσουλφονυλαμινο) βενζαμιδικων ενωσεων
BR0316107A (pt) N-alquil-4-metilenoamino-3-hidróxi-2-piridonas como antimicrobianos
DE60217432D1 (de) Verwendungen von Kohlenstofffasern
EA200700119A1 (ru) Соединения и способы лечения дислипидемии
BR122012009534B8 (pt) 4-[2-(4-metil-fenil-sulfanil)-fenil]-piperidina, seu uso e composição farmacêutica compreendendo o referido composto
NO20043176L (no) Nikotinamidderivater nyttige som P38 inhibitorer
CO5700748A2 (es) Derivados de 4-(2-fenilsulfanil-fenil)-piperidina como inhibidores de recaptacion de serotonina
WO2004108686A3 (en) Benzimidazole compounds having hypoglycemic activity
CY1106957T1 (el) Ν-σουλφονυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακοι παραγοντες
CY1109549T1 (el) Μεθοδος καταπολεμησης λοιμωξης
CO5640133A2 (es) Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de la serotonina
SE0104250D0 (sv) Heterocyclic compounds
GB0108318D0 (en) Organic compounds
ATE498600T1 (de) Inden derivate als pharmazeutika
EA200400117A1 (ru) Производные 6-[2-(фосфонометокси)алкокси]пиримидинов, обладающие антивирусной активностью, способ их получения (варианты) и способ лечения вирусной инфекции
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
ATE527996T1 (de) Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat
BR0209828A (pt) Compostos orgânicos
ATE490269T1 (de) Kristallstruktur der trypanosoma cruzi proline racemase (tcpraca) und verwendung davon
DE10394296D2 (de) Medizinische Injektionsspritze
AU2002345087A1 (en) Production of enantiomer pure 3r, 5s- (+) natrium erythro- (e)7-'4-(4-fluorophenyl)-2, 6-diisopropyl-5-methoxymethyl-pyrid-3-yl!-3, 5-dihydroxy-hept-6-e-noate
SG145572A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
DE60214397D1 (en) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität